Last reviewed · How we verify
Nicotine rescue method
Nicotine acts as an agonist at nicotinic acetylcholine receptors in the central and peripheral nervous system to reduce cravings and withdrawal symptoms in tobacco dependence.
Nicotine acts as an agonist at nicotinic acetylcholine receptors in the central and peripheral nervous system to reduce cravings and withdrawal symptoms in nicotine-dependent individuals. Used for Nicotine dependence and smoking cessation support.
At a glance
| Generic name | Nicotine rescue method |
|---|---|
| Also known as | Nicorette |
| Sponsor | VA Office of Research and Development |
| Drug class | Nicotinic acetylcholine receptor agonist |
| Target | Nicotinic acetylcholine receptors (α4β2 and other subtypes) |
| Modality | Small molecule |
| Therapeutic area | Addiction Medicine / Smoking Cessation |
| Phase | FDA-approved |
Mechanism of action
Nicotine binds to nicotinic acetylcholine receptors, particularly those containing α4β2 subunits, which are upregulated in chronic smokers. By providing exogenous nicotine through non-combustible delivery methods (patches, gum, lozenges, nasal spray, or inhalers), the drug satisfies the brain's dependence on nicotine while avoiding the harmful effects of tobacco smoke, thereby reducing withdrawal symptoms and facilitating smoking cessation.
Approved indications
- Nicotine dependence / smoking cessation
Common side effects
- Nausea
- Dizziness
- Headache
- Insomnia
- Irritability
- Local skin irritation (patch formulation)
Key clinical trials
- Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD (PHASE2)
- Pain and Smoking Study - Interactive Voice Response (NA)
- Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH) (PHASE4)
- Abstinence Reinforcement Therapy (ART) for Homeless Veteran Smokers (PHASE4)
- Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking (PHASE4)
- Mobile Contingency Management for Smoking Cessation in Returning US Veterans (NA)
- Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia (PHASE4)
- CPT and Smoking Cessation (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nicotine rescue method CI brief — competitive landscape report
- Nicotine rescue method updates RSS · CI watch RSS
- VA Office of Research and Development portfolio CI